ArticleFrontiers in pharmacology2026
miR-21-5p attenuates hyperoxia-induced lung injury by modulating YAP1-dependent ferroptosis.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bone Marrow Stem Cell Exosomes Protect Lung Cells from Oxygen Damage by Regulating miR-23a-3p/Slc7a2 Pathway.The journal of gene medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hyperoxia-induced acute lung injury (HALI) is a frequent and clinically relevant complication of oxygen therapy in critically ill patients. Excessive oxygen exposure induces severe oxidative stress and alveolar epithelial cell (AEC) injury, yet the upstream regulatory mechanisms governing regulated cell death under hyperoxic conditions remain incompletely understood. Ferroptosis, an iron-dependent form of lipid peroxidation-driven cell death, has recently been implicated in HALI pathogenesis. Methods: In this study, hyperoxia-induced AEC injury models Results: Hyperoxic exposure markedly induced ferroptosis-associated features in AECs and lung tissue, characterized by increased lipid peroxidation, iron accumulation, and impaired antioxidant capacity. miR-21-5p expression was significantly downregulated under hyperoxic conditions, whereas YAP1 expression was increased. miR-21-5p directly targeted YAP1 and negatively regulated its expression. Restoration of miR-21-5p attenuated hyperoxia-induced ferroptosis, reduced oxidative stress, and improved lung injury, while miR-21-5p deficiency exacerbated ferroptosis-related alterations and aggravated HALI. Mechanistically, modulation of the miR-21-5p/YAP1 axis was associated with coordinated changes in key ferroptosis-related molecules, including ACSL4, SLC7A11, and GPX4. Conclusion: These findings identify miR-21-5p as an important upstream regulator of ferroptosis in hyperoxia-induced lung injury through YAP1-dependent mechanisms. The miR-21-5p/YAP1 axis contributes to redox imbalance and ferroptotic susceptibility in HALI, highlighting a potential regulatory pathway relevant to hyperoxia-associated pulmonary injury.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.